|
Volumn 16, Issue 10, 2009, Pages 2752-2758
|
Management and outcomes of anorectal infection in the cancer patient
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALKYLATING AGENT;
ANTIMETABOLITE;
ANTIMITOTIC AGENT;
ANTINEOPLASTIC AGENT;
ANTINEOPLASTIC ANTIBIOTIC;
BIOLOGICAL FACTOR;
CD20 ANTIBODY;
DNA TOPOISOMERASE INHIBITOR;
EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR;
MONOCLONAL ANTIBODY CD33;
NUCLEOSIDE DERIVATIVE;
UNCLASSIFIED DRUG;
VASCULOTROPIN INHIBITOR;
ANTIINFECTIVE AGENT;
ADULT;
AGED;
ANORECTAL INFECTION;
ANUS FISTULA;
ARTICLE;
BLADDER CANCER;
BRAIN CANCER;
BREAST CANCER;
CANCER PATIENT;
CANCER SURGERY;
CARCINOID;
COHORT ANALYSIS;
COLON CANCER;
CONTROLLED STUDY;
DEBRIDEMENT;
ERYTHEMA;
FEMALE;
HEAD AND NECK CANCER;
HEMATOLOGIC MALIGNANCY;
HUMAN;
INTERNATIONAL CLASSIFICATION OF DISEASES;
INTESTINE INFECTION;
KIDNEY CANCER;
LEUKEMIA;
LUNG CANCER;
LYMPHOMA;
MAJOR CLINICAL STUDY;
MALE;
MYELODYSPLASTIC SYNDROME;
MYELOMA;
OUTCOME ASSESSMENT;
OVERALL SURVIVAL;
PANCREAS CANCER;
PERIANAL ABSCESS;
PHYSICAL EXAMINATION;
PROSTATE CANCER;
RECTUM CANCER;
RECURRENT INFECTION;
RETROSPECTIVE STUDY;
SARCOMA;
SKIN CANCER;
SOFT TISSUE INFECTION;
SOLID TUMOR;
SURGICAL MORTALITY;
SURVIVAL TIME;
TESTIS CANCER;
THROMBOCYTE COUNT;
THROMBOCYTOPENIA;
THYROID CANCER;
ANUS DISEASE;
BACTERIAL INFECTION;
CANCER STAGING;
FOLLOW UP;
MICROBIOLOGY;
MIDDLE AGED;
MULTIMODALITY CANCER THERAPY;
NEOPLASM;
PROGNOSIS;
RECTUM DISEASE;
SURVIVAL RATE;
TREATMENT OUTCOME;
ADULT;
AGED;
AGED, 80 AND OVER;
ANTI-INFECTIVE AGENTS;
ANUS DISEASES;
BACTERIAL INFECTIONS;
COHORT STUDIES;
COMBINED MODALITY THERAPY;
FEMALE;
FOLLOW-UP STUDIES;
HUMANS;
MALE;
MIDDLE AGED;
NEOPLASM STAGING;
NEOPLASMS;
PROGNOSIS;
RECTAL DISEASES;
RETROSPECTIVE STUDIES;
SURVIVAL RATE;
TREATMENT OUTCOME;
YOUNG ADULT;
|
EID: 73349104129
PISSN: 10689265
EISSN: 15344681
Source Type: Journal
DOI: 10.1245/s10434-009-0626-y Document Type: Article |
Times cited : (29)
|
References (21)
|